Your Article Summary
See Latest ArticlesCholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians
Journal of Lipid Research, 03/02/07
Wim A. van der Steeg, et al. – It is unclear whether cholesteryl ester transfer protein (CETP) contributes to high density lipoprotein cholesterol (HDL-C) levels in hyperalphalipoproteinemia (HALP) in Caucasians. Moreover, even less is known about the effects of hereditary CETP deficiency in non-Japanese. We studied 95 unrelated Caucasian individuals with HALP. No correlations between CETP concentration or activity and HDL-C were identified
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
The American Journal of Cardiology, 12/02/09
Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men
Osteoporosis International, 12/01/09
Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review
American Journal of Clinical Nutrition, 12/01/09
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of Strength and Resistance Training on Cardiovascular Disease Risk Factors and Outcomes in Older Adults
Clinics in Geriatric Medicine, 12/02/09
Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care: The EFFECT Study: A Randomized Trial
JAMA, 12/02/09
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
The American Journal of Cardiology, 12/02/09